MSD sways NICE with Simponi patient access scheme
August 26, 2011Sales and Marketing NICE, Simponi, ankylosing spondylitis
A patient access scheme which lowers Simponi’s cost has led to Merck Sharp and Dohme’s drug being given the thumbs …
Boehringer-Lilly’s Trajenta wins European approval
August 26, 2011Sales and Marketing Tradjenta, Trajenta, diabetes
Boehringer Ingelheim and Eli Lilly’s new type II diabetes drug Trajenta has been approved Europe. The European Commission backed Trajenta …
Reckitt painkiller packs may contain antipsychotics, says MHRA
August 26, 2011Manufacturing and Production, Sales and Marketing MHRA, Nurofen, Seroquel, parallel imports
Consumers in the UK are being warned to double-check packs of Reckitt Benckiser’s painkiller product Nurofen Plus following reports that …
Rock adds four new starters
August 26, 2011Medical Communications appointments, medical communications
Rock Medical Communications has appointed four new people to its specialist medical education team. Sam Flynn joins as account manager …
Google fined $500m for online drug advertising
August 26, 2011Medical Communications, Sales and Marketing Google Adwords, counterfeits, google
Google has been fined $500 million by the US government for allowing pharmacies based in Canada to advertise unlicenced drugs …
AkzoNobel appoints new investor relations director
August 25, 2011Sales and Marketing appointment, sales and marketing
Jonathan Atack is set to join AkzoNobel as the company’s new corporate director of investor relations. He was most recently …
Market access and the new NHS in England
August 25, 2011Sales and Marketing NHS, NHS reforms
The National Health Service in England is undergoing massive structural and financial upheaval, and pharma marketers will be rightly concerned …
Sharp increase in NHS diabetes prescribing costs
August 25, 2011Sales and Marketing GP prescribing, NHS, diabetes, prescribing
NHS prescribing for diabetes has risen sharply, largely driven by the disease’s growing prevalence in the UK. Spending rose 41% …
NICE says no to BMS for second-line Orencia
August 25, 2011Sales and Marketing BMS, NICE, Orencia, rheumatoid arthritis
In final draft guidance NICE has not recommended the use of Bristol-Myers Squibb’s arthritis drug Orencia after other drugs have …
inVentiv Health consolidates Europe agencies
August 25, 2011Medical Communications inVentiv Health, medical communications news
Communications group inVentiv has launched a new company which brings together all of its healthcare services under one roof. inVentiv …
FDA approves Botox to treat urinary incontinence
August 25, 2011Sales and Marketing Allergan, Botox, urinary incontinence
Botox has been approved in the US to treat urinary incontinence as manufacturer Allergan continues to expand the brand’s non-cosmetic …
Clinical research news in brief
August 24, 2011Research and Development contract research news, research and development news
Private equity firm the Carlyle Group is rumoured to be looking at buying PPD, plus there are updates from CTA/Clininvent, …
AZ details US doctor payments
August 24, 2011Sales and Marketing AstraZeneca, industry reputation, payments
AstraZeneca is shining a light on its activities in the US, disclosing for the first time how much it pays …
Spain to cut 2.4 billion euros from drugs bill with new generics rules
August 24, 2011Sales and Marketing Spain, generic prescribing, generics
The Spanish government has passed new laws to increase generic prescribing and cut billions of euros from the country’s drugs …
Blood cancer drug Adcetris approved by FDA
August 24, 2011Sales and Marketing Adcetris, Cancer, Seattle Genetics, lymphoma
The FDA has approved Seattle Genetics’ blood cancer drug Adcetris for two forms of lymphoma. Adcetris (brentuximab vedotin) can now …
Quintiles appoints Troy Norris to head up consulting group
August 24, 2011Research and Development appointment, research and development
Troy Norris has joined Quintiles as vice president and managing director for the product development and commercialisation practice at its …
UK research receives £800m funding boost
August 23, 2011Research and Development NIHR, UK research, UK science, research and development news
Research into dementia, cancer, diabetes and heart disease are among the activities to benefit from a new £800 government funding …
Zaicom Medical Marketing Communications appoints Ana Gaskill
August 23, 2011Medical Communications appointment, medical communications
Zaicom Medical Marketing Communications (Zaicom MMC) has appointed Ana Gaskill as an account director. She joins the West Sussex, UK-based …
Healthcare communications – how to influence behaviour change
August 23, 2011Medical Communications communications, healthcare communications
For decades, healthcare communications has used a fixed way of approaching patients and customers. But now we must adopt new …
FDA fast tracks Bayer prostate cancer drug
August 23, 2011Sales and Marketing Algeta, Alpharadin, Bayer, prostate cancer
Bayer’s potential blockbuster prostate cancer drug Alpharadin has been granted a fast track review by the FDA, meaning it could …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
